AURELIA ONLINE / 7.5mgの長期継続
Can Mounjaro 7.5 mg Be Used Long Term?
Whether 7.5 mg is only a transition dose, when it may be maintained long term, what to monitor, and when to increase, reduce, or stop.
Key points
- Although 7.5 mg is often used while titrating from 5 mg to 10 mg, a patient may remain on 7.5 mg when it provides adequate benefit and is tolerated.
- The goal is not to reach the highest possible dose, but to use the lowest dose that provides sufficient benefit.
7.5 mg is not always only a transition dose
- Although 7.5 mg is often used while titrating from 5 mg to 10 mg, a patient may remain on 7.5 mg when it provides adequate benefit and is tolerated.
- The goal is not to reach the highest possible dose, but to use the lowest dose that provides sufficient benefit.
Long-term monitoring
- Weight and waist trend, appetite, glucose and HbA1c when applicable.
- Nausea, vomiting, constipation, gallbladder symptoms, hydration, kidney function risk, nutrition, and muscle strength.
- Pregnancy plans, surgery, new medications, and changing health conditions.
Continue, increase, reduce, or stop
- Continue when effective and tolerated.
- Increase only when control is inadequate and adverse effects are acceptable.
- Reduce when adverse effects or inadequate nutrition appear.
- Stopping requires a plan because weight regain is common after withdrawal.
Frequently asked questions
7.5 mg is not always only a transition dose?
Although 7.5 mg is often used while titrating from 5 mg to 10 mg, a patient may remain on 7.5 mg when it provides adequate benefit and is tolerated. The goal is not to reach the highest possible dose, but to use the lowest dose that provides sufficient benefit.
Long-term monitoring?
Weight and waist trend, appetite, glucose and HbA1c when applicable. Nausea, vomiting, constipation, gallbladder symptoms, hydration, kidney function risk, nutrition, and muscle strength. Pregnancy plans, surgery, new medications, and changing health conditions.
Continue, increase, reduce, or stop?
Continue when effective and tolerated. Increase only when control is inadequate and adverse effects are acceptable. Reduce when adverse effects or inadequate nutrition appear. Stopping requires a plan because weight regain is common after withdrawal.
References
Related pages
Book an online consultationThis page provides general medical information and does not replace individual diagnosis or treatment. In Japan, Mounjaro is approved for type 2 diabetes; use for weight management is off-label. Dose changes must be decided after medical review.